Psykey, Inc. (OTCMKTS:CEOS) Short Interest Up 566.7% in May

Psykey, Inc. (OTCMKTS:CEOSGet Rating) was the target of a significant growth in short interest during the month of May. As of May 15th, there was short interest totalling 16,000 shares, a growth of 566.7% from the April 30th total of 2,400 shares. Based on an average daily trading volume, of 429,600 shares, the days-to-cover ratio is presently 0.0 days.

OTCMKTS:CEOS traded down $0.01 during trading hours on Wednesday, reaching $0.06. 374,939 shares of the company traded hands, compared to its average volume of 296,820. The business’s 50-day moving average price is $0.07 and its two-hundred day moving average price is $0.07. Psykey has a 1 year low of $0.03 and a 1 year high of $0.17.

Psykey Company Profile (Get Rating)

Psykey, Inc engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines to improve and optimize life. The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery of entheogen-based therapeutics for the psychedelic market.

See Also

Receive News & Ratings for Psykey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Psykey and related companies with MarketBeat.com's FREE daily email newsletter.